References
- Benatar M, Wuu J, Fernandez C, Weihl CC, Katzen H, Steele J, et al. Motor neuron involvement in multisystem proteinopathy: implications for ALS. Neurology. 2013; 80:1874–80.
- Kim NC, Tresse E, Kolaitis RM, Molliex A, Thomas RE, Alami NH, et al. VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations. Neuron. 2013;78:65–80.
- Johnson JO, Mandrioli J, Benatar M, Abramzon Y, van Deerlin VM, Trojanowski JQ, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857–64.
- La Spada AR, Weydt P, Pineda VV. Huntington Disease Pathogenesis: Mechanisms and Pathways. 2011.
- Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr. Neuropathological classification of Huntington disease. Journal of Neuropathology and Experimental Neurology. 1985;44:559–77.
- Rubio A, Steinberg K, Figlewicz DA, MacDonald ME, Greenamyre T, Hamill R, et al. Coexistence of Huntington disease and familial amyotrophic lateral sclerosis: case presentation. Acta Neuropathologica. 1996;92:421–7.
- Rinaldi C, Salvatore E, Giordano I, de Matteis S, Tucci T, Cinzia VR, et al. Predictors of survival in a Huntington disease population from southern Italy. Can J Neurol Sci. 2012;39: 48–51.
- Ju JS, Miller SE, Hanson PI, Weihl CC. Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP-associated disease. J Biol Chem. 2008;283: 30289–99.
- Poksay KS, Madden DT, Peter AK, Niazi K, Banwait S, Crippen D, et al. Valosin-containing protein gene mutations: cellular phenotypes relevant to neurodegeneration. J Mol Neurosci. 2011;44:91–102.